![](https://o04b8a.p3cdn1.secureserver.net/wp-content/uploads/2024/05/banner-swac25.jpg?time=1725454552)
Learning Objectives:
- Enhance understanding of the latest advancements in Extracorporeal Life Support (ECLS) therapy, including technological innovations, treatment modalities, and patient management strategies.
- Explore the multidisciplinary approach to ECLS therapy and foster collaboration among healthcare professionals from various specialties, including anaesthesiology, cardiology, cardiac surgery, transplant surgery, paediatrics, radiology, vascular surgery, and other related fields.
- Gain insights into best practices and evidence-based guidelines for the initiation, management, and weaning of ECLS therapy in both adult and pediatric populations.
- Acquire knowledge of the unique challenges and considerations in implementing ECLS services outside the cardiac operating theatre and intensive care unit, such as in the cath lab, emergency department, and general operating theatre.
- Understand the role of ELSO and its chapters in providing educational platforms, promoting quality assurance, and facilitating collaboration among ECLS professionals globally.
- Discuss the latest research findings and clinical outcomes related to ECLS therapy, including survival rates, long-term outcomes, and quality of life for ECLS patients.
- Explore the integration of ECLS therapy with other treatment modalities, such as organ transplantation, ECMO-assisted interventions, and circulatory support devices, to optimize patient outcomes.
- Gain practical skills and knowledge through hands-on workshops, including cannulation techniques, troubleshooting common ECLS complications, and simulation-based training for ECLS scenarios.
- Address the ethical, legal, and societal implications of ECLS therapy, including patient selection, resource allocation, informed consent, and end-of-life care.
- Foster networking and collaboration among participants to establish professional connections, share experiences, and promote ongoing research and development in the field of ECLS therapy.
Program Highlights:
- Meet the experts
- Pro Con debates
- Year in review
- ECMO for RV failure
- LAVA strategy for
- ECMO
- Awake ECMO
- Heparin free ECMO
- ECMO in cancer
- ECMO in burns / trauma
- ECMO for organ transplant
- Rehabilitation on ECMO
- Life after ECMO
- Paediatric and neonatal ECMO
Target Audience:
- Anaesthesiologists
- Cardiologists
- Cardiac surgeons
- Transplant surgeons
- Intensive care physicians
- Paediatricians
- Neonatologists
- Respiratory therapists
- Perfusionists
- Nurses specializing in critical care or cardiac care
- Vascular surgeons
- Emergency medicine physicians
- Clinical dietitians
- Physiotherapists
- Infectious disease specialists
- Palliative care experts
Why attending the SWAAC ELSO 2025 Conference:
SWAAC ELSO 2025 Conference offers healthcare professionals involved in ECLS therapy a unique opportunity to:
- Access the latest advancements
- Gain expert knowledge
- Collaborate with multidisciplinary teams
- Learn from real-life experiences
- Enhance practical skills
- Gain CME Hours
- Network with peers
- Contribute to the global development of ECLS therapy
It is an investment in your professional growth and, ultimately, in improving patient outcomes and quality of care.